Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 66,516 | 21,608 | 6,077 | 0 | 0 |
| Cost of Goods | 6,383 | 4,046 | 1,526 | N/A | N/A |
| Gross Profit | 60,133 | 17,562 | 4,551 | N/A | N/A |
| Operating Expenses | 83,910 | 81,174 | 82,517 | 78,182 | 73,202 |
| Operating Income | -23,394 | -63,566 | -77,440 | -78,182 | -73,202 |
| Interest Expense | 1,079 | 0 | 0 | 0 | 0 |
| Other Income | 128 | -512 | 260 | 350 | 337 |
| Pre-tax Income | -24,345 | -64,078 | -77,180 | -77,832 | -72,865 |
| Net Income Continuous | -24,345 | -64,078 | -77,180 | -77,832 | -72,865 |
| Net Income | $-24,345 | $-64,078 | $-77,180 | $-77,832 | $-72,865 |
| EPS Basic Total Ops | -0.65 | -1.71 | -2.07 | -2.10 | -1.97 |
| EPS Basic Continuous Ops | -0.65 | -1.70 | -2.07 | -2.10 | -1.97 |
| EPS Diluted Total Ops | -0.65 | -1.71 | -2.07 | -2.10 | -1.97 |
| EPS Diluted Continuous Ops | -0.65 | -1.70 | -2.07 | -2.10 | -1.97 |
| EBITDA(a) | $-22,053 | $-62,206 | $-76,540 | $-77,908 | $-72,925 |